Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schellong

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Klinische Padiatrie|July 1, 1982
[Chemotherapy of different intensity and reduced radiotherapy of Hodgkin's disease in childhood--a report on 170 patients of the cooperative study HD 78]H Breu, G Schellong, I Grosch-Wörner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in childrenR Pötter, F Roes, G Schellong, et al.
Bone Marrow Transplantation|January 1, 1991
Role and perspectives of BMT in AML: the BFM experienceT Klingebiel, J Ritter, G Schellong, et al.
Klinische Padiatrie|July 4, 2003
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlookW Dörffel, H Lüders, U Rühl, et al.
Klinische Padiatrie|May 1, 1984
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]S Müller-Weihrich, J Beck, G Henze, et al.
Bone Marrow Transplantation|December 1, 1989
Actual role and perspectives of BMT in childrenD Niethammer, R Dopfer, T Klingebiel, et al.
Klinische Padiatrie|July 1, 1994
[Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study]G Schellong, I Hörnig-Franz, B Rath, et al.
Bone Marrow Transplantation|January 1, 1991
Role and perspectives of BMT in ALL: the BFM experienceD Niethammer, T Klingebiel, H Riehm, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Klinische Padiatrie|May 1, 1988
[Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85]G Schellong, I Hörnig, J Brämswig, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Klinische Padiatrie|July 1, 1982
[Chemotherapy of different intensity and reduced radiotherapy of Hodgkin's disease in childhood--a report on 170 patients of the cooperative study HD 78]H Breu, G Schellong, I Grosch-Wörner, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
Subclinical impairment of renal function after radiotherapy for Hodgkin's disease in childrenR Pötter, F Roes, G Schellong, et al.
Bone Marrow Transplantation|January 1, 1991
Role and perspectives of BMT in AML: the BFM experienceT Klingebiel, J Ritter, G Schellong, et al.
Klinische Padiatrie|July 4, 2003
Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlookW Dörffel, H Lüders, U Rühl, et al.
Klinische Padiatrie|May 1, 1984
[BFM study 1981/83 of the treatment of highly malignant non-Hodgkin's lymphoma in children: results of therapy stratified according to histologic immunological type and clinical stage]S Müller-Weihrich, J Beck, G Henze, et al.
Bone Marrow Transplantation|December 1, 1989
Actual role and perspectives of BMT in childrenD Niethammer, R Dopfer, T Klingebiel, et al.
Klinische Padiatrie|July 1, 1994
[Reducing radiation dosage to 20-30 Gy in combined chemo-/radiotherapy of Hodgkin's disease in childhood. A report of the cooperative DAL-HD-87 therapy study]G Schellong, I Hörnig-Franz, B Rath, et al.
Bone Marrow Transplantation|January 1, 1991
Role and perspectives of BMT in ALL: the BFM experienceD Niethammer, T Klingebiel, H Riehm, et al.
Blood|January 11, 2000
Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group reportA Reiter, M Schrappe, W D Ludwig, et al.
Klinische Padiatrie|May 1, 1988
[Significance of procarbazine in the chemotherapy of Hodgkin's disease--a report of the Cooperative Therapy Study DAL-HD-85]G Schellong, I Hörnig, J Brämswig, et al.
Pageof 14